一个合成,结构研究,抗瘤活性和两个decavanadate化合物的分子对接方法
Rihab Dridi1, Zaineb Abdelkafi-Koubaa2, Najet Srairi-Abid3
1University of Tunis El Manar, Faculty of Sciences of Tunis, Laboratory of Materials, Crystal Chemistry and Applied Thermodynamics, 2092 El Manar II, Tunis, Tunisia.
Journal of inorganic biochemistry
|March 28, 2024
概括
两种新型的德卡瓦纳达特化合物显示出对人类大脑和乳腺癌细胞的显著抗癌潜力. 这些化合物在分子对接研究中表现出剂量依赖的抗增殖活性和优越的结合亲和力,与西斯普拉丁相比.
科学领域:
- 无机化学 无机化学
- 材料科学 材料科学 材料科学
- 药用化学 医学化学
背景情况:
- 德卡瓦纳达特协调化合物具有独特的结构和电子特性.
- 开发具有提高疗效和降低毒性的新型抗癌药物是研究的一个关键领域.
- 金属有机化合物正在研究其治疗潜力.
研究的目的:
- 合成和描述两种新型的甲卡瓦纳达特协调化合物.
- 研究这些化合物对人类癌症细胞系的细胞毒性和抗增殖活性.
- 通过分子对接研究来评估它们作为抗癌剂的潜力.
主要方法:
- 通过红外光谱学,紫外线可见分析和单晶X射线衍射进行合成和表征.
- 细胞毒性和抗增殖作用对U87 (质母细胞瘤) 和MDA-MB-231 (乳腺癌) 细胞系的体外评估.
- 对选择的蛋白质点进行分子对接模拟.
主要成果:
- 两种德卡瓦纳化合物[C6H13N4]2][MgH2O]6]2[O28V10].6H2O (1) 和[C7H11N2]4][MgH2O]6][O28V10].4H2O (2) 已成功合成并进行了表征.
- 这两种化合物都对U87和MDA-MB-231细胞表现出剂量依赖的抗增殖活性,IC50值处于小微分子范围.
- 分子对接揭示了化合物1和2对受体的结合亲和力比西斯普拉丁更好,这表明它有可能作为大脑和乳腺细胞中的蛋白质抑制剂.
结论:
- 合成的dcavanadate化合物显示出作为抗癌剂的巨大潜力.
- 它们对人类癌细胞的有效性和有利的分子对接配置文件需要进一步研究.
- 这些发现有助于开发基于的新型抗癌疗法.
相关概念视频
Structure-Activity Relationships and Drug Design
716
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
716
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
954
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
954
Cycloaddition Reactions: Overview
2.6K
Cycloadditions are one of the most valuable and effective synthesis routes to form cyclic compounds. These are concerted pericyclic reactions between two unsaturated compounds resulting in a cyclic product with two new σ bonds formed at the expense of π bonds. The [4 + 2] cycloaddition, known as the Diels–Alder reaction, is the most common. The other example is a [2 + 2] cycloaddition.
2.6K
Local Anesthetics: Chemistry and Structure-Activity Relationship
4.4K
Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
4.4K


